* Minerva Neurosciences Inc is expected to show no change in quarterly revenue when it reports results on July 30 (estimated) for the period ending June 30 2024
*
* LSEG's mean analyst estimate for Minerva Neurosciences Inc is for a loss of 97 cents per share.
* The one available analyst rating on the shares is "hold".
* The mean earnings estimate of analysts was unchanged in the last three months.
* Wall Street's median 12-month price target for Minerva Neurosciences Inc is $7.00, above its last closing price of $3.12.
This summary was machine generated July 26 at 13:51 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments